Register of vitiligo patients in the UK
Part of Skin clinical trials.
This study creates a UK-wide registry (a secure list of patient information) for children and adults with vitiligo. Researchers will collect data over time to understand how vitiligo affects people, support research, and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have vitiligo diagnosed by a skin specialist (dermatologist).
- You or your child must be under the care of a hospital skin clinic.
- You (and your child, if appropriate) must give permission to be in the study and to let the study team see your medical records for many years.
- You must be able to read and understand English well enough to complete simple questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks the safety and effectiveness of vitiligo medications over time. It helps doctors learn how well treatments work for adults and teens with nonsegmental vitiligo.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This study is looking at whether levels of certain immune proteins (called cytokines) in your blood can help predict how vitiligo will progress. By participating, you help doctors develop a tool to better plan treatment and understand your condition.
This study looks at differences in the gut and skin microbiome (the germs living in and on the body) in people with vitiligo and in people without vitiligo. It aims to understand what might be linked to how vitiligo spreads over time.
This study looks at how vitiligo affects your daily life, work, and overall well-being. By answering a few questionnaires, you help researchers understand the real impact of vitiligo, which could lead to better support and treatments.
Hear when a new Dermatologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.